Learning to Cope Better After Uveal Melanoma Diagnosis
Promoting Adjustment in Uveal Melanoma Survivorship: A Randomized Trial Targeting Illness Perceptions
In Plain English
This study is about helping you feel less scared and worried after being diagnosed with uveal melanoma. Researchers know that eye cancer patients often feel uncertain about what comes next—whether your vision will stay the same, how treatment might affect you, and whether the cancer could spread. This trial tests whether watching educational videos can help you understand your diagnosis better and feel more in control. You'll be randomly placed into one of two groups. One group watches two 15-minute videos that explain uveal melanoma, what to expect during treatment and recovery, and how to manage the emotional side of having cancer. Both groups also get a sheet with mental health resources you can use. The study will check whether the videos help reduce feelings of depression and anxiety, and whether they help you feel less threatened by your diagnosis. This isn't about curing cancer—it's about helping you cope emotionally and mentally during your cancer journey.
What This Trial Does
This clinical trial evaluates a video-based psychoeducational intervention for patients with uveal melanoma. Uveal melanoma (UM) is a rare intraocular cancer. UM patients face an uncertain course of survivorship in terms of their visual acuity, treatment-related side effects, and risk for eventual metastasis of the cancer. Learning about patients' thoughts and reactions to informational resources may better support patients during ocular melanoma survivorship.
How It Works
PRIMARY OBJECTIVE: I. To assess the efficacy of the psychoeducation intervention (compared to the control condition) in modifying illness perceptions of disease control, chronicity, and coherence (i.e., to become less threatening) over the course of the follow-up period. SECONDARY OBJECTIVE: I. To assess the efficacy of the psychoeducation intervention (compared to the control condition) in reducing the degree of participant's depressive and anxiety symptoms over the course of the follow-up period. OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants watch two fifteen-minute educational videos and receive a mental health resource information sheet on study. ARM II: Patients receive enhanced treatment as usual and receive a mental health resource information sheet on study.
Who Can Join
Inclusion Criteria
- Adults (age 18 years and older at visit 1)
- History of uveal melanoma as documented in their University of California, Los Angeles (UCLA) medical record
- Receipt of uveal melanoma treatment and/or ongoing follow-up care at the UCLA Jules Stein Eye Institute, as documented in their UCLA medical record
- Ability to read, write, and converse in English
- Access to the internet via a computer or cell phone
- Access to a personal email address
- Written informed consent obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study
Exclusion Criteria
Treatments
Education for Intervention (BEHAVIORAL)
Participants watch two fifteen-minute educational videos and receive a mental health resource information sheet on study.
Best Practice (BEHAVIORAL)
Patients receive enhanced treatment as usual and receive a mental health resource information sheet on study.
Trial Sites (1)
University of California at Los Angeles
Los Angeles, California, United States